Skip to Content
Search Menu

PPI use and its impact on the disease course of ulcerative colitis

At this year’s UEG Week 2023, researchers from Norway are highlighting PPI use and its potential impact on ulcerative colitis (UC) disease course.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Relateret indhold

Mehdi Osooli

Reducing Opioid Use in Inflammatory Bowel Disease: A Critical Need

/ Mehdi Osooli
ECCO25IBD Play the Video 06:52
Arun Sridhar

How Does Different Classes of IBD Drugs Affect Intestinal Epithelial Homeostasis and Function?

/ Arun Sridhar
IBDUEGW24 Play the Video 4:40

Hospitalisation with Infectious Mononucleosis Increases Risk of Inflammatory Bowel Disease

/ Rahma Elmahdi
IBDUEGW24
Jonas Julius Rudbæk

Unidentified Trigger can Prompt Pathological Changes Many Years Prior to Clinical Onset of Crohn’s Disease and Colitis Ulcerosa

/ Jonas Julius Rudbæk
CrohnsIBDUlcerative colitis Play the Video 13:37
Abhinav Vasudevan

Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease

/ Abhinav Vasudevan
CrohnsIBDUlcerative colitis Play the Video 06:43
Maiara Brusco De Freitas

Impaired Growth and Nutritional Status Can Be Observed Several Years Before Diagnosis of Childhood-Onset IBD

/ Maiara Brusco De Freitas
CrohnsIBDUlcerative colitis Play the Video 6:10

The Impact of the Gut Microbiota on Chronic Pouchitis and Fecal Microbiota Transplantation as a New Treatment

/ Sabrina Just Kousgaard
IBDTreatment

Patients’ Experience of Home Parenteral Support Care in Denmark – A Balance Between Sufficient Support and Independence

/ Mette Holst / Louise Bangsgaard Antonsen / Henrik Højgaard Rasmussen / Palle Bekker Jeppesen
IBD

The Danish Intestinal Failure Group Takes Stock of Patients with Chronic Intestinal Failure and Treatment

/ Mette Holst / Louise Bangsgaard Antonsen / Henrik Højgaard Rasmussen / Palle Bekker Jeppesen
IBD
Back to top